Treat Alzheimer’s Disease Differently with Generic Namenda Memantine Drug part 2

Mechanism of Action

Glutamate is the chief excitant neurochemical present in the brain. It is thought that excess stimulation of neurons or nerve cells by glutamate may be accountable for the devolution of nerves that happens in some neurological disorders, for instance Alzheimer's disease. Glutamate is quite similar to other neurotransmitters as it is generated and discharged by nerve cells in the brain. After its discharge, glutamate  moves to neighboring nerve cells where it accompanies a receptor or sense organ on the surface of the cells named the N-methyl-D-aspartate (NMDA). Namenda Memantine  (Japanese : メマンティン ) HCl begins its work by blocking the receptor, thereby reducing the impacts of glutamate. The thinking behind this action is that by hindering the NMDA receptor and the impacts of glutamate, generic Namenda may save nerve cells from superfluous arousal by glutamate. The US Food and Drug Administration (FDA) extended its approval for Memantine in October, 2003.